• News
    • News
    • Upcoming Events
    • Subscribe
  • Our Company
    • Our Story
    • Our Vision
    • Board of Directors
    • Alzinova Team
    • Advisers & Collaborators
  • Patients & Families
    • Alzheimer's Patients
    • Impact on Society
    • The Unmet Medical Need
  • R & D
    • Alzheimer's Disease
    • Our Programs
    • Specific Targeting of Toxic Aβ Oligomers
    • The AβCC Peptide™ Technology
    • Scientific Presentations
  • Investors
    • Overview
    • News
    • Analyses
    • Press Releases
      • English
      • Swedish
      • Subscribe
    • Presentations
    • Board and Management
    • The Share
    • Financial Reports
      • Financial Reports - English
      • Financial Reports – Swedish
      • Financial Calendar
    • Corporate Governance
    • General Meetings
    • IR Contact
  • Career
  • Contact
logo
  • News
    • News
    • Upcoming Events
    • Subscribe
  • Our Company
    • Our Story
    • Our Vision
    • Board of Directors
    • Alzinova Team
    • Advisers & Collaborators
  • Patients & Families
    • Alzheimer's Patients
    • Impact on Society
    • The Unmet Medical Need
  • R & D
    • Alzheimer's Disease
    • Our Programs
    • Specific Targeting of Toxic Aβ Oligomers
    • The AβCC Peptide™ Technology
    • Scientific Presentations
  • Investors
    • Overview
    • News
    • Analyses
    • Press Releases
      • English
      • Swedish
      • Subscribe
    • Presentations
    • Board and Management
    • The Share
    • Financial Reports
      • Financial Reports - English
      • Financial Reports – Swedish
      • Financial Calendar
    • Corporate Governance
    • General Meetings
    • IR Contact
  • Career
  • Contact
Home / General Meetings
  • Overview
  • News
  • Analyses
  • Press Releases
    • English
    • Swedish
    • Subscribe
  • Presentations
  • Board and Management
  • The Share
  • Financial Reports
    • Financial Reports - English
    • Financial Reports – Swedish
    • Financial Calendar
  • Corporate Governance
  • General Meetings
  • IR Contact

General Meetings

Annual General Meeting, 28th of May 2025

  • Minutes of AGM meeting
  • Notice of AGM (in English)
  • Notice of AGM (in Swedish)
  • Proxy form for AGM (in English)
  • Proxy form for AGM (in Swedish)
  • Articles of association (in Swedish) / Bolagsordning årsstämma

Extraordinary General Meeting, 7th of March 2025

  • Minutes of EGM Meeting
  • Press release, bulletin from AGM (in English)
  • Pressmeddelande från årsstämma (in Swedish)
  • Notice of EGM (in English)
  • Notice of EGM (in Swedish)
  • Proxy form for EGM (in English)
  • Proxy form for EGM (in Swedish)
  • Full proposal and fullt terms and conditions
  • Fullständigt förslag jämte fullständiga villkor
  • Alzinova AB revisors yttrande
  • Alzinova AB styrelsens redogörelse

Nomination Committee

Previous Nomination Committees

 

 

Previous General Meetings

Annual General Meeting, 29th of May 2024

  • Minutes of Meeting AGM (Protokoll årsstämma), in Swedish
  • Press release, bulletin from AGM (in English)
  • Pressmeddelande från årsstämma (in Swedish)
  • Notice of AGM (in English)
  • Notice of AGM (in Swedish)
  • Proxy form for AGM (in English)
  • Proxy form for AGM (in Swedish)
  • Item 15. The Board of Directors’ of Alzinova AB (publ) proposed resolution on a directed issue of shares / Punkt 15. Styrelsens förslag till beslut om riktad nyemission av aktier
  • Item 16. Decision on amendment of the articles of association (in Swedish) / Punkt 16. Beslut om ändring av bolagsordningen
  • The Board of Directors’ report referred to in Chapter 13, section 7 / Styrelsens redogörelse enligt 13.7
  • Auditor’s statement as referred to in Chapter 13, Section 8 / Revisorsyttrande enligt 13.8
  • CEO Presentation

Annual General Meeting, 30th of May 2023

  • Minutes of Meeting AGM (Protokoll årsstämma), in Swedish
  • Press release, bulletin from AGM (in English)
  • Pressmeddelande från årsstämma (in Swedish)
  • Notice of AGM (in English)
  • Notice of AGM (in Swedish)
  • Proxy form for AGM (in English)
  • Proxy form for AGM (in Swedish)
  • CEO Presentation

Annual General Meeting, 18th of May 2022

  • Minutes of Meeting AGM (Protokoll årsstämma), in Swedish
  • Press release, bulletin from AGM (in English)
  • Pressmeddelande från årsstämma (in Swedish)
  • Notice of AGM (in English)
  • Notice of AGM (in Swedish)
  • Proxy form for AGM (in English)
  • Proxy form for AGM (in Swedish)
  • Punkt 14 a) i). Styrelsens förslag till ny bolagsordning
  • Punkt 14 a) ii). Styrelsens förslag till ny bolagsordning
  • Punkt 14b. Styrelsens beslut om företrädesemission
  • Punkt 14b Bilaga A, fullständiga villkor teckningsoption TO3
  • Punkt 15. Beslut om riktad nyemission av aktier (Sv)
  • Item 15. Resolution on directed issue of shares (Eng)
  • Styrelsens redogörelse över väsentliga händelser
  • Revisorns yttrande enligt 13.16 och 14.8 perioden 2022-04-13 –2022-04-13
  • Styrelsens redogörelse enligt 13-7
  • Revisorns yttrande enligt 13 kap 7 § ABL
  • CEO Presentation

Annual General Meeting, 18th of May 2021

  • Minutes from the AG (in Swedish)
  • Notice of AGM (in English)
  • Notice of AGM (in Swedish)
  • Registration to attend AGM, and form for postal voting (in Swedish)
  • Proxy form for AGM (in Swedish)

Annual General Meeting, 14th of May 2020

  • Notice of AGM (in English) 
  • Notice of AGM (in Swedish) 
  • Terms for Subscription Warrants in favour of Board of Directors (in Swedish) 
  • Terms for Subscription Warrants in favour of key personnel (in Swedish) 
  • Proposal for long term incentive program in favour of Board of Directors (in Swedish) 
  • Proposal for long term incentive program in favour of key personnel (in Swedish)
  • Minutes from the AGM (in Swedish)

Extraordinary General Meeting, 27th of February 2020

  • Press release, notice of EGM
  • Press release, report from the EGM
  • Minutes from the EGM
  • Proposal new director of the board

Annual General Meeting, 16th of May 2019

  • Press release, report from the AGM
  • Press release, notice of AGM
  • Minutes from the AGM
  • Proposal amended articles of association

Extraordinary General Meeting, 26th of March 2019

  • Press release, report from the EGM
  • Press release, notice of AGM
  • Minutes from the EGM
  • Amended articles of association

Extraordinary General Meeting, 9th of November 2018

  • Press release, report from the EGM
  • Press release, notice of EGM
  • Minutes from the EGM
  • Authorisation preferential rights issue
  • Authorisation directed rights issue

Annual General Meeting, 17th of May 2018

  • Press release, report from the AGM
  • Press release, notice of AGM
  • Minutes from the AGM
  • Register of votes
  • Amended articles of association

Annual General Meeting, 17th of May 2017

  • Press release, report from the AGM
  • Press release, notice of AGM
  • Minutes from the AGM
  • Register of votes
  • Amended articles of association

 

 

Annual General Meeting, 18th of May 2016

  • Press release, report from the AGM
  • Press release, notice of AGM
  • Minutes from the AGM
  • Register of votes
  • Amended articles of association
  • News
  • Our Company
  • Patients & Families
  • R & D
  • Investors
  • Contact

Alzinova AB, Gemenskapens gata 9,  SE-431 53 Mölndal
info@alzinova.com

Follow us on

follow us on linkedin